Mid-Sized European Companies Eager to Acquire During Growth Spurt

The first half of 2016 saw two of Europe’s mid-sized pharmaceutical companies snapping up compatriot companies while busily growing sales and profits. They’re not just taking out assets from under the noses of Europe’s Big Pharma firms, they’re showing companies can still be built on the back of good ideas and rigorous business development planning, at relatively low price-tags.

Milan, Italy-based Recordati Industria Chimica & Farmaceutica SPA is a case in point, having acquired Milan-based Italchimici SPA in May 2016 for €130m ($144m) for its gastroenterology and respiratory products, and the Swiss company